[1]
|
Hu, M., Bogoyevitch, M.A. and Jans, D.A. (2020) Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies. Physiological Reviews, 100, 1527-1594.
https://doi.org/10.1152/physrev.00030.2019
|
[2]
|
Li, Y., Wang, X., Blau, D.M., et al. (2022) Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Chil-dren Younger than 5 Years in 2019: A Systematic Analysis. The Lancet, 399, 2047-2064. https://doi.org/10.1016/S0140-6736(22)00478-0
|
[3]
|
Luna, M.S., Manzoni, P., Paes, B., et al. (2020) Expert Consensus on Palivizumab Use for Respiratory Syncytial Virus in Developed Countries. Paediatric Respiratory Reviews, 33, 35-44. https://doi.org/10.1016/j.prrv.2018.12.001
|
[4]
|
Thwaites, R., Buchan, S., Fullarton, J., et al. (2020) Clinical Burden of Severe Respiratory Syncytial Virus Infection during the First 2 Years of Life in Children Born be-tween 2000 and 2011 in Scotland. European Journal of Pediatrics, 179, 791-799. https://doi.org/10.1007/s00431-019-03564-9
|
[5]
|
Cai, W., Buda, S., Schuler, E., et al. (2020) Risk Factors for Hospitalized Respiratory Syncytial Virus Disease and Its Severe Outcomes. Influenza and Other Respiratory Viruses, 14, 658-670. https://doi.org/10.1111/irv.12729
|
[6]
|
Shi, T., Vennard, S., Mahdy, S., Nair, H. and RESCEU Investi-gators (2022) Risk Factors for Poor Outcome or Death in Young Children with Respiratory Syncytial Virus-Associated Acute Lower Respiratory Tract Infection: A Systematic Review and Meta-Analysis. The Journal of Infectious Diseases, 226, S10-S16.
https://doi.org/10.1093/infdis/jiaa751
|
[7]
|
Chaw, P.S., Wong, S.W.L., Cunningham, S., et al. (2020) Acute Lower Respiratory Infections Associated with Respiratory Syncytial Virus in Children with Underlying Congenital Heart Dis-ease: Systematic Review and Meta-Analysis. The Journal of Infectious Diseases, 222, S613-S619.
|
[8]
|
Chaw, P.S., Hua, L., Cunningham, S., et al. (2020) Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children with Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis. The Journal of Infectious Diseases, 222, S620-S627
|
[9]
|
Manzoni, P., Figueras-Aloy, J., Simões, E.A.F., et al. (2017) Defining the Incidence and Associ-ated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection among Children with Chronic Diseases. Infectious Diseases and Therapy, 6, 383-411. https://doi.org/10.1007/s40121-017-0160-3
|
[10]
|
Beckhaus, A.A. and Castro-Rodriguez, J.A. (2018) Down Syndrome and the Risk of Severe RSV Infection: A Meta-Analysis. Pediatrics, 142, e20180225. https://doi.org/10.1542/peds.2018-0225
|
[11]
|
Shmueli, E., Goldberg, O., Mei-Zahav, M., et al. (2021) Risk Factors for Respiratory Syncytial Virus Bronchiolitis Hospitalizations in Children with Chronic Diseases. Pediatric Pulmonology, 56, 2204-2211.
https://doi.org/10.1002/ppul.25435
|
[12]
|
Mitra, S., El Azrak, M., McCord, H. and Paes, B.A. (2018) Hospitaliza-tion for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis. The Journal of Pediatrics, 203, 92-100.E3. https://doi.org/10.1016/j.jpeds.2018.08.006
|
[13]
|
Okamoto, K., Morio, T., Nakamura, Y., et al. (2021) Hospitalisa-tions Due to Respiratory Syncytial Virus Infection in Children with Down Syndrome before and after Palivizumab Rec-ommendation in Japan. Acta Paediatrica, 110, 1299-1306. https://doi.org/10.1111/apa.15641
|
[14]
|
Santoro, S.L., Chicoine, B., Jasien, J.M., et al. (2021) Pneumonia and Respiratory Infections in Down Syndrome: A Scoping Review of the Literature. American Journal of Medical Genetics Part A, 185, 286-299.
https://doi.org/10.1002/ajmg.a.61924
|
[15]
|
Ramphul, K., Mejias, S.G. and Joynauth, J. (2019) Children Less than 2 with Down Syndrome and Suffering from Respiratory Syncytial Virus Have a Longer and More Costly Hospitalization. The Journal of Pediatrics, 206, 302.
https://doi.org/10.1016/j.jpeds.2018.11.047
|
[16]
|
Illouz, T., Biragyn, A., Iulita, M.F., et al. (2021) Immune Dysreg-ulation and the Increased Risk of Complications and Mortality following Respiratory Tract Infections in Adults with Down Syndrome. Frontiers in Immunology, 12, Article 621440. https://doi.org/10.3389/fimmu.2021.621440
|
[17]
|
Zhang, X., Chen, L., Wang, X., et al. (2020) Changes in Maternal Age and Prevalence of Congenital Anomalies during the Enactment of China’s Universal Two-Child Policy (2013-2017) in Zhejiang Province, China: An Observational Study. PLOS MEDICINE, 17, e1003047. https://doi.org/10.1371/journal.pmed.1003047
|
[18]
|
Jama-Alol, K.A., Moore, H.C., Jacoby, P., Bower, C. and Lehmann, D. (2014) Morbidity Due to Acute Lower Respiratory Infection in Children with Birth Defects: A Total Popu-lation-Based Linked Data Study. BMC Pediatrics, 14, Article No. 80. https://doi.org/10.1186/1471-2431-14-80
|
[19]
|
Chan, M., Park, J.J., Shi, T., et al. (2017) The Burden of Respirato-ry Syncytial Virus (RSV) Associated Acute Lower Respiratory Infections in Children with Down Syndrome: A System-atic Review and Meta-Analysis. Journal of Global Health, 7, Article ID: 020413. https://doi.org/10.7189/jogh.07.020413
|
[20]
|
Yi, H., Lanctôt, K.L., Bont, L., et al. (2014) Respiratory Syncytial Vi-rus Prophylaxis in Down Syndrome: A Prospective Cohort Study. Pediatrics, 133, 1031-1037. https://doi.org/10.1542/peds.2013-3916
|
[21]
|
Stagliano, D.R., Nylund, C.M., Eide, M.B. and Eberly, M.D. (2015) Children with Down Syndrome Are High-Risk for Severe Respiratory Syncytial Virus Disease. The Journal of Pediat-rics, 166, 703-709.e2.
https://doi.org/10.1016/j.jpeds.2014.11.058
|
[22]
|
Blake, J.M., Estrada Gomez, D., Skotko, B.G., Torres, A. and Santoro, S.L. (2021) Pneumonia and Respiratory Infection in Down Syndrome: A 10-Year Cohort Analysis of Inpatient and Outpatient Encounters across the Lifespan. American Journal of Medical Genetics Part A, 185, 2878-2887. https://doi.org/10.1002/ajmg.a.62355
|
[23]
|
Stanley, M.A., Shepherd, N., Duvall, N., et al. (2019) Clinical Identifi-cation of Feeding and Swallowing Disorders in 0-6 Month Old Infants with Down Syndrome. American Journal of Medical Genetics Part A, 179, 177-182.
https://doi.org/10.1002/ajmg.a.11
|
[24]
|
Eijsvoogel, N.B., Verstegen, R.H.J., van Well, G.T.J., et al. (2022) In-creased Rate of Respiratory Symptoms in Children with Down Syndrome: A 2-Year Web-Based Parent-Reported Pro-spective Study. European Journal of Pediatrics, 181, 4079-4089. https://doi.org/10.1007/s00431-022-04634-1
|
[25]
|
Zachariah, P., Ruttenber, M. and Simões, E.A.F. (2012) Down Syndrome and Hospitalizations Due to Respiratory Syncytial Virus: A Population-Based Study. The Journal of Pediat-rics, 160, 827-831.e1.
https://doi.org/10.1016/j.jpeds.2011.11.004
|
[26]
|
Löwensteyn, Y.N., Phijffer, E.W.E.M., Simons, J.V.L., et al. (2020) Respiratory Syncytial Virus-Related Death in Children with Down Syndrome: The RSV GOLD Study. The Pedi-atric Infectious Disease Journal, 39, 665-670.
https://doi.org/10.1097/INF.0000000000002666
|
[27]
|
Antonarakis, S.E., Skotko, B.G., Rafii, M.S., et al. (2020) Down Syndrome. Nature Reviews Disease Primer. Nature Reviews Disease Primers, 6, Article No. 9. https://doi.org/10.1038/s41572-019-0143-7
|
[28]
|
Lagan, N., Huggard, D., Mc Grane, F., et al. (2020) Multiorgan Involvement and Management in Children with Down Syndrome. Acta Paediatrica, 109, 1096-1111. https://doi.org/10.1111/apa.15153
|
[29]
|
Gandy, K.C., Castillo, H.A., Ouellette, L., et al. (2020) The Relationship between Chronic Health Conditions and Cognitive Deficits in Children, Adolescents, and Young Adults with Down Syndrome: A Systematic Review. PLOS ONE, 15, e0239040. https://doi.org/10.1371/journal.pone.0239040
|
[30]
|
Kats, D.J., Roche, K.J. and Skotko, B.G. (2020) Epileptic Spasms in Individuals with Down Syndrome: A Review of the Current Literature. Epilepsia Open, 5, 344-353. https://doi.org/10.1002/epi4.12412
|
[31]
|
Santoro, J.D., Pagarkar, D., Chu, D.T., et al. (2021) Neurologic Complica-tions of Down Syndrome: A Systematic Review. Journal of Neurology, 268, 4495-4509. https://doi.org/10.1007/s00415-020-10179-w
|
[32]
|
Paes, B., Kim, D., Saleem, M., et al. (2019) Respiratory Syn-cytial Virus Prophylaxis in Infants with Congenital Airway Anomalies Compared to Standard Indications and Complex Medical Disorders. European Journal of Pediatrics, 178, 377-385. https://doi.org/10.1007/s00431-018-03308-1
|
[33]
|
Gupte, A., Al-Antary, E.T., Edwards, H., et al. (2022) The Par-adox of Myeloid Leukemia Associated with Down Syndrome. Biochemical Pharmacology, 201, Article ID: 115046. https://doi.org/10.1016/j.bcp.2022.115046
|
[34]
|
Kimura, D., McNamara, I.F., Wang, J., et al. (2019) Pulmonary Hypertension during Respiratory Syncytial Virus Bronchiolitis: A Risk Factor for Severity of Illness. Cardiology in the Young, 29, 615-619.
https://doi.org/10.1017/S1047951119000313
|
[35]
|
De Lausnay, M., Verhulst, S., Boel, L., et al. (2020) The Preva-lence of Lower Airway Anomalies in Children with Down Syndrome Compared to Controls. Pediatric Pulmonology, 55, 1259-1263. https://doi.org/10.1002/ppul.24741
|
[36]
|
Alsubie, H.S. and Rosen, D. (2018) The Evaluation and Management of Respiratory Disease in Children with Down Syndrome (DS). Paediatric Respiratory Reviews, 26, 49-54. https://doi.org/10.1016/j.prrv.2017.07.003
|
[37]
|
Fockens, M.M., Hölscher, M., Limpens, J. and Dikkers, F.G. (2021) Tracheal Anomalies Associated with Down Syndrome: A Systematic Review. Pediatric Pulmonology, 56, 814-822. https://doi.org/10.1002/ppul.25203
|
[38]
|
Wang, T., Xu, Q., Dai, G., et al. (2021) Clinical Characteristics of Children with Airway Malacia Complicated by Pneumonia. BMC Infectious Diseases, 21, Article No. 902. https://doi.org/10.1186/s12879-021-06603-9
|
[39]
|
Danopoulos, S., Deutsch, G.H., Dumortier, C., Mariani, T.J. and Al Alam, D. (2021) Lung Disease Manifestations in Down Syndrome. American Journal of Physiology-Lung Cellular and Molecular Physiology, 321, L892-L899.
https://doi.org/10.1152/ajplung.00434.2020
|
[40]
|
Huggard, D., McGrane, F., Lagan, N., et al. (2018) Altered En-dotoxin Responsiveness in Healthy Children with Down Syndrome. BMC Immunology, 19, Article No. 31. https://doi.org/10.1186/s12865-018-0270-z
|
[41]
|
Bloemers, B.L.P., van Bleek, G.M., Kimpen, J.L.L. and Bont, L. (2010) Distinct Abnormalities in the Innate Immune System of Children with Down Syndrome. The Journal of Pediat-rics, 156, 809.e1-809.e5.
https://doi.org/10.1016/j.jpeds.2009.12.006
|
[42]
|
Huggard, D., Koay, W.J., Kelly, L., et al. (2019) Altered Toll-Like Receptor Signalling in Children with Down Syndrome. Mediators of Inflammation, 2019, Article ID: 4068734. https://doi.org/10.1155/2019/4068734
|
[43]
|
Huggard, D., Doherty, D.G. and Molloy, E.J. (2020) Immune Dysreg-ulation in Children with Down Syndrome. Frontiers in Pediatrics, 8, Article 73. https://doi.org/10.3389/fped.2020.00073
|
[44]
|
Seckin, A.N., Ozdemir, H., Ceylan, A. and Artac, H. (2018) Age-Related Alterations of the CD19 Complex and Memory B Cells in Children with Down Syndrome. Clinical and Experimental Medicine, 18, 125-131.
https://doi.org/10.1007/s10238-017-0457-2
|